Related Experiment Videos
Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD
Jeffrey D Amack1, Shannon R Reagan, Mani S Mahadevan
1Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706, USA.
The Journal of Cell Biology
|November 13, 2002
Summary
Myotonic dystrophy type 1 (DM1) disrupts muscle cell differentiation by reducing MyoD protein levels. Restoring MyoD rescues this defect, indicating its critical role in myoblast differentiation.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Myotonic dystrophy (DM) is linked to repeat expansion mutations (DM1 and DM2).
- Pathogenic RNA molecules from these mutations form nuclear foci.
- The DM1 mutation involves a CTG expansion in the DMPK 3'-UTR.
Purpose of the Study:
- Investigate how mutant 3'-UTR RNA disrupts myoblast differentiation in a cell culture model.
- Determine the molecular mechanism underlying the differentiation defect in DM1.
Main Methods:
- Utilized a cell culture model of DM1 using C2C12 myoblasts.
- Expressed mutant DMPK 3'-UTR transcripts in C2C12 myoblasts.
- Monitored MyoD protein levels and E-box-mediated gene expression during differentiation.
Main Results:
- Mutant DMPK 3'-UTR transcripts significantly reduced MyoD protein levels within 6 hours of differentiation.
- This reduction correlated with impaired E-box-mediated gene expression.
- Restoring MyoD levels rescued the differentiation defect in the cell model.
Conclusions:
- Mutant DMPK 3'-UTR transcripts disrupt myoblast differentiation by lowering MyoD levels.
- MyoD is essential for activating the differentiation program in myoblasts.
- This mechanism provides insight into the pathogenesis of myotonic dystrophy type 1.